Chemotherapy with Idarubicin, Ara-C,VP-16, Amsacrine, Followed by G-CSF and Maintenance Immunotherapy with Interleukin-2 for Patients with High-Risk Acute Myeloid leukemia: a 3-Years Follow-Up
Year: 1998
Type: book-chapter
Study design: Clinical Trial
Source: Hämatologie und Bluttransfusion
Institutions: University Hospital Frankfurt, Medizinische Hochschule Hannover, Städtisches Klinikum Karlsruhe, Nuremberg Hospital, Universitätsklinikum Aachen, RWTH Aachen University, München Klinik Harlaching, Krankenhaus Nordwest, Jena University Hospital, Friedrich Schiller University Jena, Philipps University of Marburg, Universitätsklinikum Gießen und Marburg, Helios Dr. Horst Schmidt Kliniken Wiesbaden, Johannes Gutenberg University Mainz
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: high-risk acute myeloid leukemia, idarubicin, cytarabine, etoposide, amsacrine, granulocyte colony-stimulating factor, interleukin-2, maintenance immunotherapy, complete remission, consolidation chemotherapy, myelodysplastic syndrome, secondary acute myeloid leukemia, overall survival, relapse-free survival, allogeneic bone marrow transplantation
Open Access status: closed
OpenAlex ID: W25229641
